Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits

Lead: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits

This episode of 'This Week in Addiction Medicine' tackles the crucial topic of benzodiazepine tapering guidelines. The American Society of Addiction Medicine (ASAM), alongside other medical bodies, has crafted evidence-based recommendations to help clinicians make informed decisions about tapering these medications. The focus is on balancing risks and benefits, with a clear message that abrupt discontinuation should be avoided due to potential withdrawal risks.

Instead, a personalised approach is encouraged, taking into account each patient's unique response and providing psychosocial support throughout the process. You'll find insights into how shared decision-making can empower patients and ensure their safety during tapering. Additionally, the episode explores studies on cannabis use and cardiovascular risks, prescription misuse in telehealth settings, and cognitive behavioural interventions for co-occurring disorders. These discussions are packed with research findings and expert opinions, making them highly relevant for anyone interested in addiction medicine.

The host, Zach Caruso, presents these complex topics with clarity and a touch of light humour, making it accessible even if you're not a medical professional. The conversation also touches on the need for increased oversight of social media algorithms due to their addictive nature, drawing parallels to substance use disorders. If you're curious about the latest in addiction medicine or want to understand the implications of benzodiazepine tapering, this episode is a must-listen.

It offers valuable perspectives and practical advice that can be life-changing for patients and healthcare providers alike.